Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Prolonged Response to Anti-PD-1 Antibody Therapy in Chemotherapy-Refractory Cholangiocarcinoma With High Tumor Mutational Burden.

Gbolahan O, Hashemi-Sadraei N, O'Neil B.

J Natl Compr Canc Netw. 2019 Jun 1;17(6):644-648. doi: 10.6004/jnccn.2019.7304.

PMID:
31200359
2.

Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.

Gbolahan OB, Tong Y, Sehdev A, O'Neil B, Shahda S.

BMC Cancer. 2019 May 17;19(1):468. doi: 10.1186/s12885-019-5630-4.

3.

Integrating geriatric assessment into routine gastrointestinal (GI) consultation: The Cancer and Aging Resilience Evaluation (CARE).

Williams GR, Kenzik KM, Parman M, Al-Obaidi M, Francisco L, Rocque GB, McDonald A, Paluri R, Navari RM, Nandagopal L, Gbolahan O, Young-Smith C, Robertson M, Bhatia S.

J Geriatr Oncol. 2019 Apr 17. pii: S1879-4068(19)30081-5. doi: 10.1016/j.jgo.2019.04.008. [Epub ahead of print]

PMID:
31005648
4.

Update on systemic therapy for colorectal cancer: biologics take sides.

Gbolahan O, O'Neil B.

Transl Gastroenterol Hepatol. 2019 Feb 13;4:9. doi: 10.21037/tgh.2019.01.12. eCollection 2019. Review.

5.

Germline and Somatic DNA Damage Repair Gene Mutations and Overall Survival in Metastatic Pancreatic Adenocarcinoma Patients Treated with FOLFIRINOX.

Sehdev A, Gbolahan O, Hancock BA, Stanley M, Shahda S, Wan J, Wu HH, Radovich M, O'Neil BH.

Clin Cancer Res. 2018 Dec 15;24(24):6204-6211. doi: 10.1158/1078-0432.CCR-18-1472. Epub 2018 Aug 21.

PMID:
30131383
6.

A Phase II Study of Pemetrexed in Patients with Recurrent Thymoma and Thymic Carcinoma.

Gbolahan OB, Porter RF, Salter JT, Yiannoutsos C, Burns M, Chiorean EG, Loehrer PJ Sr.

J Thorac Oncol. 2018 Dec;13(12):1940-1948. doi: 10.1016/j.jtho.2018.07.094. Epub 2018 Aug 16.

PMID:
30121390
7.

Clinical Characteristics of Patients Experiencing Pathologic Complete Response Following Neoadjuvant Therapy for Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.

Hashemi-Sadraei N, Gbolahan OB, Salfity H, O'Neil B, House MG, Shahda S.

Am J Clin Oncol. 2018 Oct;41(10):982-985. doi: 10.1097/COC.0000000000000409.

PMID:
28968257
8.

Immunotherapeutic Concepts to Target Acute Myeloid Leukemia: Focusing on the Role of Monoclonal Antibodies, Hypomethylating Agents and the Leukemic Microenvironment.

Gbolahan OB, Zeidan AM, Stahl M, Abu Zaid M, Farag S, Paczesny S, Konig H.

Int J Mol Sci. 2017 Jul 31;18(8). pii: E1660. doi: 10.3390/ijms18081660. Review.

9.

Locoregional and systemic therapy for hepatocellular carcinoma.

Gbolahan OB, Schacht MA, Beckley EW, LaRoche TP, O'Neil BH, Pyko M.

J Gastrointest Oncol. 2017 Apr;8(2):215-228. doi: 10.21037/jgo.2017.03.13. Review.

10.

Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis.

Tatler AL, Goodwin AT, Gbolahan O, Saini G, Porte J, John AE, Clifford RL, Violette SM, Weinreb PH, Parfrey H, Wolters PJ, Gauldie J, Kolb M, Jenkins G.

PLoS One. 2016 Aug 5;11(8):e0158047. doi: 10.1371/journal.pone.0158047. eCollection 2016.

11.

Re: Comparative proteome analysis revealing an 11-protein signature for aggressive triple-negative breast cancer.

Bakinde N, Gbolahan O, Ibraheem A.

J Natl Cancer Inst. 2014 Sep 29;106(9). pii: dju253. doi: 10.1093/jnci/dju253. Print 2014 Sep. No abstract available.

PMID:
25265941

Supplemental Content

Loading ...
Support Center